Eterna Therapeutics Inc (NAS:ERNA)
$ 2.06 0.07 (3.52%) Market Cap: 11.14 Mil Enterprise Value: 53.48 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

Brooklyn Immunotherapeutics Inc Annual Shareholders Meeting Transcript

Jun 07, 2022 / 03:00PM GMT
Release Date Price: $12.42 (+1.49%)
Operator

Good day, and welcome to the Brooklyn ImmunoTherapeutics Annual Meeting of Stockholders. I would now like to turn the conference over to Matt Angel, Interim CEO. Please, go ahead.

Matt Angel
Brooklyn ImmunoTherapeutics, Inc. - CEO

Good morning, ladies and gentlemen. I am Matt Angel, and I am the Interim Chief Executive Officer and a director of Brooklyn ImmunoTherapeutics, Inc. It is a pleasure to welcome you to our 2022 Annual Meeting of Stockholders.

We are holding a virtual annual meeting of stockholders, which means the annual meeting takes place exclusively via Internet webcast. Stockholders attending the virtual meeting via Internet webcast may vote their shares online in real time until the polls are closed. The polls to vote online are currently open. If you have already submitted a proxy to vote your shares, you do not need to submit an online ballot, unless you want to change your vote.

We have asked Andrew Jackson, our Chief Financial Officer and Corporate Secretary, to record the minutes of this meeting; and Jim Alden of American

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot